Literature DB >> 18928892

Optimizing skeletal muscle reinnervation with nerve transfer.

Samuel C Lien1, Paul S Cederna, William M Kuzon.   

Abstract

Denervation as a consequence of nerve injury causes profound structural and functional changes within skeletal muscle and can lead to a marked impairment in function of the affected limb. Prompt reinnervation of a muscle with a sufficient number of motion-specific motor axons generally results in good structural and functional recovery, whereas long-term denervation or insufficient or improper axonal recruitment uniformly results in poor functional recovery. Only nerve transfer has been highly efficacious in changing the clinical outcomes of patients with skeletal muscle denervation, especially in the case of proximal limb nerve injuries. Rapid reinnervation with an abundant number of motor axons remains the only clinically effective means to restore function to denervated skeletal muscles.

Entities:  

Mesh:

Year:  2008        PMID: 18928892     DOI: 10.1016/j.hcl.2008.08.001

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  9 in total

1.  Does partial muscle reinnervation preserve future re-innervation potential?

Authors:  Jonathan Isaacs; Satya Mallu; Mary Shall; Gaurangkumar Patel; Pooja Shah; Shalin Shah; Mark A Feger; Gordon Graham; Nikhil Pasula
Journal:  Muscle Nerve       Date:  2017-03-17       Impact factor: 3.217

2.  Follistatin Protein Enhances Satellite Cell Counts in Reinnervated Muscle.

Authors:  Mark A Feger; Jonathan Isaacs; Satya Mallu; Dorne Yager; Mary Shall; Gaurangkumar Patel; Omar Protzuk; Akhil S Bokkisam
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2022-06-21

3.  Effects of 4-Aminopyridine on Combined Nerve and Muscle Injury and Bone Loss.

Authors:  Prem Kumar Govindappa; Mashanipalya G Jagadeeshaprasad; Peter Tortora; M A Hassan Talukder; John C Elfar
Journal:  J Hand Surg Am       Date:  2022-04-10       Impact factor: 2.342

4.  Purposeful Misalignment of Severed Nerve Stumps in a Standardized Transection Model Reveals Persistent Functional Deficit With Aberrant Neurofilament Distribution.

Authors:  Jung Il Lee; Anagha A Gurjar; M A Hassan Talukder; Andrew Rodenhouse; Kristen Manto; Mary O'Brien; Zara Karuman; Prem Kumar Govindappa; John C Elfar
Journal:  Mil Med       Date:  2021-01-25       Impact factor: 1.437

5.  Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy.

Authors:  Guang-Liang Jiang; Yu-Dong Gu; Li-Yin Zhang; Li-Ying Shen; Cong Yu; Jian-Guang Xu
Journal:  ISRN Pharm       Date:  2011-08-15

6.  Transdermal delivery of 4-aminopyridine accelerates motor functional recovery and improves nerve morphology following sciatic nerve crush injury in mice.

Authors:  Andrew R Clark; Chia George Hsu; M A Hassan Talukder; Mark Noble; John C Elfar
Journal:  Neural Regen Res       Date:  2020-01       Impact factor: 5.135

7.  A novel nerve transection and repair method in mice: histomorphometric analysis of nerves, blood vessels, and muscles with functional recovery.

Authors:  Jung Il Lee; Anagha A Gurjar; M A Hassan Talukder; Andrew Rodenhouse; Kristen Manto; Mary O'Brien; Prem Kumar Govindappa; John C Elfar
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

8.  Functional recovery and muscle atrophy in pre-clinical models of peripheral nerve transection and gap-grafting in mice: effects of 4-aminopyridine.

Authors:  Jung Il Lee; M A Hassan Talukder; Zara Karuman; Anagha A Gurjar; Prem Kumar Govindappa; Jagadeeshaprasad M Guddadarangaiah; Kristen M Manto; Grant D Wandling; John P Hegarty; David L Waning; John C Elfar
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

9.  (4-Aminopyridine)-PLGA-PEG as a Novel Thermosensitive and Locally Injectable Treatment for Acute Peripheral Nerve Injury.

Authors:  Kristen M Manto; Prem Kumar Govindappa; Daniele Parisi; Zara Karuman; Brandon Martinazzi; John P Hegarty; M A Hassan Talukder; John C Elfar
Journal:  ACS Appl Bio Mater       Date:  2021-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.